Lxir Medilabs Private Limited

Lxir Medilabs Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
CIN U51909HR2019PTC078734 Incorporated 22 February 2019 ROC Haryana HQ Panchkula, Haryana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹19.32 Cr
▲ 20% YoY
Net profit · FY 2025
₹5.48 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹81.66 Lakh
EBITDA margin 4.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹6.55 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings

About Lxir Medilabs Private Limited

Data last updated:

Lxir Medilabs Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2019PTC078734. Its GSTIN is 06AADCL8593R1ZJ (Haryana). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lata Jindal and Jatin Jindal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 48 Mdc Scetor – 5, Panchkula, Haryana, India – 134109.

As per the financials filed for FY 2025, the company reported a revenue of ₹19.32 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹5.48 Lakh (net margin 0.3%) and EBITDA of ₹81.66 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.

As per MCA filings, the company has open charges of ₹6.55 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending.

Lxir Medilabs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0006237). For more details, the company can be reached via its website lxir.co.in.

Company details

CIN U51909HR2019PTC078734
Registration Number 078734
Incorporation Date 22 February 2019
ROC Haryana
Listing Status Unlisted
Company Status Active
MSME Classification Small
Udyam Registration UDYAM-HR-13-0006237

Recognitions & Rankings of Lxir Medilabs

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-HR-13-0006237

Contact details

Lxir Medilabs Private Limited's registered office is in Panchkula, Haryana. Its website is lxir.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    SCO 48 Mdc Scetor – 5, Panchkula, Haryana, India – 134109
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Lxir Medilabs Private Limited, buy the company report.

Comprehensive company report
Lxir Medilabs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Lxir Medilabs is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Lxir Medilabs Private Limited, buy the company report.

Financials of Lxir Medilabs Private Limited

FY 2025 filings available

Lxir Medilabs Private Limited reported revenue of ₹19.32 Cr (up 20% YoY) for FY 2025.

Revenue · FY 2025
₹19.32 Cr ▲ 20%
Net profit · FY 2025
₹5.48 Lakh margin 0.3%
EBITDA · FY 2025
₹81.66 Lakh margin 4.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 49%
5 years · compounded
▲ 156%

Revenue has grown at a compounded annual rate (CAGR) of 15% over three years, including 20% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹81.66 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.48 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.2%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Lxir Medilabs Private Limited, buy the company report.

Board of directors of Lxir Medilabs Private Limited

Lxir Medilabs has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Lata JindalDirector22 Feb 20197 Years 8 MonthsCurrent
Jatin JindalDirector22 Feb 20197 Years 8 MonthsCurrent

Peer comparison

Lxir Medilabs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Avlaan Pharmaceutical Private Limited₹19.36 Cr (FY 2024)28.0%Chennai, Tamil Nadu, India
Medic Biologicals and Pharmaceuticals Private Limited₹19.33 Cr (FY 2025)26.0%Thiruvananthapuram, Kerala, India
Lxir Medilabs Private Limitedthis company₹19.32 Cr (FY 2025)₹5.48 Lakh0.3%20.0%Panchkula, Haryana, India
Delius Pharmaceuticals Private Limited₹19.28 Cr (FY 2024)7.0%New Delhi, Delhi, India
Anax Lifescience Private Limited₹19.25 Cr (FY 2024)9.0%Ahmedabad, Gujarat, India
Curosis Healthcare Private Limited₹19.23 Cr (FY 2024)16.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Lxir Medilabs Private Limited, buy the company report.

Auditor

Lxir Medilabs Private Limited is audited by N K ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
N K ASSOCIATESFY 2023009872N

Shareholding

The shareholding of Lxir Medilabs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Lxir Medilabs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹6.55 Cr
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹6.55 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Sep 2023100821607Hdfc Bank Limited₹5 LakhOpen
17 Oct 2022100624395Hdfc Bank Limited₹6.5 CrOpen

To see the full charge records of Lxir Medilabs Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Lxir Medilabs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Lxir Medilabs has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
06AADCL8593R1ZJHaryanaActive16 Mar 2019
02AADCL8593R1ZRHimachal PradeshActive30 May 2022

To see the full GST registrations and return filing status of Lxir Medilabs Private Limited, buy the company report.

Recent activity

Lxir Medilabs Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Jatin Jindal was appointed as Director on 22 Feb 2019.

AGM
Lxir Medilabs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 650.00 Lakh registered on 17 Oct 2022 with Charge ID 100624395 was modified on 22 Sep 2025.
Filing
Lxir Medilabs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Lakh with Charge ID 100821607 was registered on 22 Sep 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 650.00 Lakh with Charge ID 100624395 was registered on 17 Oct 2022.
Appointed
Jatin Jindal was appointed as Director.
Appointed
Lata Jindal was appointed as Director.
Incorporation
22 Feb 2019
Lxir Medilabs Private Limited was registered on 22 Feb 2019 with Roc Haryana & aged 7 years 8 months as per MCA records.

Frequently asked questions

Lxir Medilabs is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2019 (7+ years old) and is registered under CIN U51909HR2019PTC078734.

Lxir Medilabs has 2 current directors:

The latest financial statements of Lxir Medilabs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Lxir Medilabs is 06AADCL8593R1ZJ, registered in Haryana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AADCL8593R1ZR (Himachal Pradesh).

The CIN (Corporate Identification Number) of Lxir Medilabs is U51909HR2019PTC078734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lxir Medilabs has 4 court cases on record: 4 filed by the company. 3 are pending.

Lxir Medilabs was incorporated on 22 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.

The peers of Lxir Medilabs by revenue are Avlaan Pharmaceutical Private Limited, Medic Biologicals and Pharmaceuticals Private Limited, Delius Pharmaceuticals Private Limited, Anax Lifescience Private Limited, Curosis Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Jatin Jindal was appointed as Director on 22 Feb 2019. Lata Jindal was appointed as Director on 22 Feb 2019.

Yes, Lxir Medilabs is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0006237).

Lxir Medilabs can be reached through the website lxir.co.in. Its registered office is in Panchkula, Haryana, India.